Biomerica, Inc.
BMRA
$3.78
$0.02130.57%
NASDAQ
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.12M | 1.64M | 1.81M | 1.12M | 1.02M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.12M | 1.64M | 1.81M | 1.12M | 1.02M |
| Cost of Revenue | 1.10M | 1.20M | 1.52M | 1.10M | 1.17M |
| Gross Profit | 19.00K | 437.00K | 289.00K | 20.00K | -149.00K |
| SG&A Expenses | 1.01M | 1.17M | 1.36M | 1.28M | 1.51M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.33M | 2.63M | 3.18M | 2.64M | 3.02M |
| Operating Income | -1.21M | -993.00K | -1.37M | -1.53M | -2.00M |
| Income Before Tax | -1.17M | -953.00K | -1.31M | -1.41M | -1.91M |
| Income Tax Expenses | -4.00K | -3.00K | 4.00K | 7.00K | 4.00K |
| Earnings from Continuing Operations | -1.16M | -950.00K | -1.32M | -1.42M | -1.92M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.16M | -950.00K | -1.32M | -1.42M | -1.92M |
| EBIT | -1.21M | -993.00K | -1.37M | -1.53M | -2.00M |
| EBITDA | -1.19M | -971.00K | -1.35M | -1.51M | -1.98M |
| EPS Basic | -0.48 | -0.44 | -0.63 | -0.68 | -0.91 |
| Normalized Basic EPS | -0.30 | -0.28 | -0.39 | -0.42 | -0.57 |
| EPS Diluted | -0.48 | -0.48 | -0.64 | -0.72 | -0.91 |
| Normalized Diluted EPS | -0.30 | -0.28 | -0.39 | -0.42 | -0.57 |
| Average Basic Shares Outstanding | 2.40M | 2.14M | 2.10M | 2.10M | 2.10M |
| Average Diluted Shares Outstanding | 2.40M | 2.14M | 2.10M | 2.10M | 2.10M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |